BioCryst Pharmaceuticals (BCRX) Stock Forecast & Price Prediction

Estimation of the future price movement of BioCryst Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $5.62

Concensus $19.00

Low $14.00

Median $19.00

High $25.00

Based on analysts projections #BCRX is expected to experience a positive growth trajectory over the next year.

The current average BCRX price target, as estimated by these analysts, is $19.00.

The predictions for the future BCRX stock price range from a low of $14.00 to a high of $25.00, highlighting the variability of market expectations for BCRX.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

BCRX stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Liisa Bayko
Evercore ISI
November 2, 2022 Buy 16.00 12.39
Gena Wang
August 23, 2022 Buy 14.00 14.33
Ken Cacciatore
Cowen & Co.
January 10, 2022 Buy 25.00 14.78
Brian Cheng
Cantor Fitzgerald
November 3, 2021 Buy 21.00 12.40
Maury Raycroft
August 9, 2021 Buy 19.00 17.65

BioCryst Pharmaceuticals (BCRX) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if BioCryst Pharmaceuticals is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.


Financial Scores

Updated on: 03/03/2024

Altman Z-Score: 3.6

Piotroski Score: 4.0

ESG Score

Updated on: 03/03/2024

Environmental: 59.4

Social: 64.8

Governance: 58.1

Financial Health

Updated on: 03/03/2024

DCF: Strong Buy

ROE: Neutral

ROA: Strong Buy

Debt to equity ratio: Strong Sell

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Sell

BCRX Discounted Cash Flow

Updated on: 03/03/2024

Discounted Cash Flow Value

Current Price

BCRX Revenues by Segment

Updated on: 03/03/2024

Collaborative And Other Research And Development

Revenue from Contract with Customer, Excluding Assessed Tax

BCRX Revenues by Region

Updated on: 03/03/2024

No available data

BCRX Notes Due

Updated on: 03/03/2024


There are no data to display

BioCryst Pharmaceuticals (BCRX) Social Sentiments

Monitoring bullish and bearish sentiments towards BioCryst Pharmaceuticals on Twitter and Stocktwits could help to forecast an upward or downward trend in BioCryst Pharmaceuticals stock price.

Analyzing Biocryst Pharmaceuticals' Stock Forecast: The Promise and Perils of Rare Disease Treatments

BioCryst Pharmaceuticals is a biotechnology company focused on the development and commercialization of treatments for rare diseases. With a focus on small molecules that target key enzymes, BioCryst has been able to develop drugs that have shown promise in treating various medical conditions. One of the key areas of focus for BioCryst has been hereditary angioedema (HAE), which is a... Read more

Predicting the Future: BioCryst Stock in the Biotechnology Sector

The biotechnology stock market sector is a dynamic and exciting area for investors looking to capitalize on scientific advancements in the field of medicine. Biotech companies are involved in researching, developing, and producing drugs, vaccines, and therapies that improve patient outcomes. One prominent player in this market is BioCryst Pharmaceuticals (stock ticker: BCRX). Based in Durham, North Carolina, BioCryst specializes... Read more